Psivida Corp. (PSDV) Skips to Late Stage Trials

Northern, WI 7/19/12 (traderscorner) -- Psivida Corp. (NASDAQ: PSDV) was cleared by regulators to skip initial studies and proceed directly to late stage trials with their new eye insert. This send the share price up over 55% in morning trading. See Disclaimer Here

Distributed by Viestly